Esophagectomy
Esophagectomy is a medical procedure with 51 clinical trials. Currently 17 active trials ongoing. Historical success rate of 73.9%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
14
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
70.8%
17 of 24 finished
29.2%
7 ended early
17
trials recruiting
51
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Infiltration Pattern of Locally Advanced ESCC
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Shanghai Clinical Cohort - Esophageal Cancer
Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy
Clinical Trials (51)
Infiltration Pattern of Locally Advanced ESCC
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Shanghai Clinical Cohort - Esophageal Cancer
Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy
Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
Retrospective Review of Esophageal Cancer at MSKCC
Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
Machine Learning to Predict Lymph Node Metastasis in T1 Esophageal Squamous Cell Carcinoma
Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal Carcinoma
Esophagectomy: Sweet Versus Ivor-Lewis (ESVIL) (ECTOP-2001)
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 51